Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Inhalation sciences | 220,000 | net | 27 Apr 2023 | tx 2+220,000 |
| Genovis AB | 40,000 | net | 28 Aug 2019 | tx 5+40,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Apr 2023 | PURCHASE | Inhalation sciences | 70,000 | 3.60 SEK | first after silence |
| 22 Jun 2020 | GRANT_AWARD | Inhalation sciences | 150,000 | 1.10 SEK | deriv |
| 28 Aug 2019 | PURCHASE | Genovis AB | 4,828 | 22.50 SEK | |
| 28 Aug 2019 | PURCHASE | Genovis AB | 11,407 | 22.60 SEK | |
| 28 Aug 2019 | PURCHASE | Genovis AB | 20,765 | 22.70 SEK | |
| 28 Aug 2019 | PURCHASE | Genovis AB | 450 | 22.90 SEK | |
| 28 Aug 2019 | PURCHASE | Genovis AB | 2,550 | 23.00 SEK |
1 purchase reported after at least 12 months of silence — most recent on 27 Apr 2023.